000			01949 a2200481 4500
005			20250514215808.0
264		0	_c20050705
008			200507s 0 0 eng d
022			_a0022-3565
024	7		_a10.1124/jpet.104.079285 _2doi
040			_aNLM _beng _cNLM
100	1		_aSivarao, Digavalli V
245	0	0	_aEffect of 4-(5-chloro-2-hydroxyphenyl)-3-(2-hydroxyethyl)-6-(trifluoromethyl)-quinolin-2(1H)-one (BMS-223131), a novel opener of large conductance Ca2+-activated K+ (maxi-K) channels on normal and stress-aggravated colonic motility and visceral nociception. _h[electronic resource]
260			_bThe Journal of pharmacology and experimental therapeutics _cMay 2005
300			_a840-7 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAnimals
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aColon _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aGastrointestinal Motility _xdrug effects
650	0	4	_aIon Channel Gating _xdrug effects
650	0	4	_aLarge-Conductance Calcium-Activated Potassium Channels
650	0	4	_aPain Measurement _xdrug effects
650	0	4	_aPotassium Channels, Calcium-Activated _xagonists
650	0	4	_aQuinolines _xadministration & dosage
650	0	4	_aQuinolones _xadministration & dosage
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aStress, Physiological _xdrug therapy
650	0	4	_aViscera _xdrug effects
700	1		_aNewberry, Kimberly
700	1		_aLangdon, Shaun
700	1		_aLee, Alicia V
700	1		_aHewawasam, Piyasena
700	1		_aPlym, Mary Jane
700	1		_aSignor, Laura
700	1		_aMyers, Robert
700	1		_aLodge, Nicholas J
773	0		_tThe Journal of pharmacology and experimental therapeutics _gvol. 313 _gno. 2 _gp. 840-7
856	4	0	_uhttps://doi.org/10.1124/jpet.104.079285 _zAvailable from publisher's website
999			_c15378178 _d15378178